NETRI

Since 2018, NETRI has developed a unique value proposition on the organs-on-chip market. NETRI solutions offer to generate the level of data (throughput) and biological complexity (relevance) required to validate the predictive nature of compounds in humans, with 3 main areas of differentiation: • High-throughput & interoperable devices: compartmentalization, pump-free and compatible with laboratory equipment. NETRI is convinced that the future of drug trials will focus on the rapid, replicable generation of large volumes of biological data (for artificial intelligence processing), generated with the increased translation offered by organs-on-chip (OoCs) , helping to limit animal experimentation. In this context, NETRI addresses the dermo-cosmetics, pharmaceutical and food health markets to meet their specific challenges. NETRI positions itself within its ecosystem and in relation to its competitors as the only player enabling the innervation and vascularization of any organ, constituting a competitive advantage and a strategic barrier to entry for its direct competitors. NETRI is an industrial start-up that provides human cell-based assays to catalog and learn the complex language of human neurons and translate for pharmaceutical, nutrition & dermo-cosmetics industries developing treatment across all applications. With its holistic approach, NETRI builds the knowledge to bridge between laboratory discovery, human biology and pathophysiology by integrating its organs-on-chip technologies into clients’ standardized processes. NETRI accompanies its clients throughout the development life of their product by providing predictive datas or platforms to understand modes of action in discovery, preclinical or clinical phases.